AirSculpt Technologies, Inc. (NASDAQ:AIRS – Get Free Report) major shareholder Jorey Chernett acquired 83,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were acquired at an average cost of $2.56 per share, for a total transaction of $212,480.00. Following the completion of the acquisition, the insider owned 6,676,059 shares of the company’s stock, valued at $17,090,711.04. This trade represents a 1.26% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Jorey Chernett also recently made the following trade(s):
- On Monday, March 16th, Jorey Chernett acquired 105,848 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.43 per share, with a total value of $257,210.64.
- On Wednesday, March 11th, Jorey Chernett bought 88,000 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.15 per share, with a total value of $189,200.00.
- On Friday, March 6th, Jorey Chernett bought 45,600 shares of AirSculpt Technologies stock. The shares were bought at an average cost of $2.00 per share, for a total transaction of $91,200.00.
- On Wednesday, March 4th, Jorey Chernett purchased 30,000 shares of AirSculpt Technologies stock. The stock was bought at an average price of $1.87 per share, for a total transaction of $56,100.00.
- On Tuesday, March 3rd, Jorey Chernett purchased 80,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $1.71 per share, with a total value of $136,800.00.
AirSculpt Technologies Stock Up 3.2%
Shares of NASDAQ AIRS traded up $0.09 during mid-day trading on Wednesday, reaching $2.78. 1,815,407 shares of the company were exchanged, compared to its average volume of 2,756,208. AirSculpt Technologies, Inc. has a 1 year low of $1.51 and a 1 year high of $12.00. The firm has a 50-day moving average of $2.24 and a 200 day moving average of $4.63. The stock has a market cap of $173.27 million, a price-to-earnings ratio of -9.25 and a beta of 2.75. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63.
Analysts Set New Price Targets
Read Our Latest Stock Report on AIRS
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in AIRS. Invesco Ltd. acquired a new position in AirSculpt Technologies during the 1st quarter valued at about $56,000. Creative Planning grew its stake in shares of AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock worth $64,000 after acquiring an additional 3,224 shares during the last quarter. Citizens Financial Group Inc. RI grew its stake in shares of AirSculpt Technologies by 49.1% during the second quarter. Citizens Financial Group Inc. RI now owns 147,900 shares of the company’s stock worth $714,000 after acquiring an additional 48,734 shares during the last quarter. XTX Topco Ltd increased its holdings in shares of AirSculpt Technologies by 54.2% during the second quarter. XTX Topco Ltd now owns 45,485 shares of the company’s stock valued at $220,000 after acquiring an additional 15,979 shares in the last quarter. Finally, Quadrature Capital Ltd acquired a new position in shares of AirSculpt Technologies during the second quarter valued at about $78,000. 91.54% of the stock is currently owned by hedge funds and other institutional investors.
About AirSculpt Technologies
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculptĀ® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Further Reading
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
